{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:44:28Z","timestamp":1794473068577,"version":"4.9.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"KMU-innovativ","award":["031A061C"],"award-info":[{"award-number":["031A061C"]}]},{"name":"KMU-innovativ","award":["031A061A"],"award-info":[{"award-number":["031A061A"]}]},{"name":"KMU-innovativ","award":["0315802"],"award-info":[{"award-number":["0315802"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004746","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T13:49:36Z","timestamp":1466689776000},"page":"e0004746","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":202,"title":["An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs"],"prefix":"10.1371","volume":"10","author":[{"given":"Margit","family":"Schnee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette B.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Petsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Baumhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kramps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Stitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","article-title":"Human rabies: neuropathogenesis, diagnosis, and management","volume":"12","author":"T Hemachudha","year":"2013","journal-title":"Lancet Neurology"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-11-63","article-title":"Diagnosis, management and post-mortem findings of a human case of rabies imported into the United Kingdom from India: a case report","volume":"11","author":"S Pathak","year":"2014","journal-title":"Virology Journal"},{"key":"ref3","article-title":"Novel vaccines to human rabies","volume":"3","author":"HCJ Ertl","year":"2009","journal-title":"PLoS neglected tropical diseases"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"TJ Wiktor","year":"1973","journal-title":"Journal of Immunology (Baltimore, Md: 1950)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"JH Cox","year":"1977","journal-title":"Infection and Immunity"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.01342-07","article-title":"Double-labeled rabies virus: live tracking of enveloped virus transport","volume":"82","author":"Y Klingen","year":"2008","journal-title":"Journal of Virology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.antiviral.2013.03.011","article-title":"Eliminating canine rabies, the principal source of human infection: what will it take?","volume":"98","author":"FX Meslin","year":"2013","journal-title":"Antiviral Res"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.3201\/eid1909.130083","article-title":"Enzootic and epizootic rabies associated with vampire bats, peru","volume":"19","author":"RE Condori-Condori","year":"2013","journal-title":"Emerging Infectious Diseases"},{"key":"ref9","article-title":"Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs","volume":"3","author":"P-PAM van Thiel","year":"2009","journal-title":"PLoS neglected tropical diseases"},{"key":"ref10","unstructured":"World Health O (2013) WHO Expert Consultation on Rabies. Second report. World Health Organization Technical Report Series: 1\u2013139, back cover."},{"key":"ref11","first-page":"1","article-title":"Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention","author":"CE Rupprecht","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.13.19166-en","article-title":"Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe?","volume":"14","author":"H Bourhy","year":"2009","journal-title":"Euro Surveill"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1128\/JVI.02470-12","article-title":"A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein","volume":"87","author":"R Amann","year":"2013","journal-title":"Journal of Virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#","article-title":"In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies","volume":"30","author":"I Hoerr","year":"2000","journal-title":"Eur J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"M Fotin-Mleczek","year":"2011","journal-title":"J Immunother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0022219412463435","article-title":"Differentiating Literacy Growth of ELL Students With LD From Other High-Risk Subgroups and General Education Peers: Evidence From Grades 3\u201310","volume":"47","author":"EJ Solari","year":"2012","journal-title":"J Learn Disabil"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4161\/hv.25181","article-title":"A novel, disruptive vaccination technology: self-adjuvanted RNActive vaccines","volume":"9","author":"K-J Kallen","year":"2013","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/wrna.1189","article-title":"Messenger RNA-based vaccines: progress, challenges, applications","volume":"4","author":"T Kramps","year":"2013","journal-title":"Wiley interdisciplinary reviews RNA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"U Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/14712598.4.8.1285","article-title":"Messenger RNA-based vaccines","volume":"4","author":"S Pascolo","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14760584.2015.1000871","article-title":"The messenger&apos;s great message for vaccination","volume":"14","author":"S Pascolo","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1007\/s00018-004-4255-0","article-title":"Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines","volume":"61","author":"JP Carralot","year":"2004","journal-title":"Cellular and molecular life sciences: CMLS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/eji.200425656","article-title":"Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA","volume":"35","author":"B Scheel","year":"2005","journal-title":"European Journal of Immunology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-vaccine technologies","volume":"9","author":"T Schlake","year":"2012","journal-title":"RNA biology"},{"issue":"Pt 4","key":"ref25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1469-7580.1997.19040601.x","article-title":"Confocal laser scanning microscopy of porcine skin: implications for human wound healing studies","volume":"190","author":"NJ Vardaxis","year":"1997","journal-title":"J Anat"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1524-475x.2001.00066.x","article-title":"The pig as a model for human wound healing","volume":"9","author":"TP Sullivan","year":"2001","journal-title":"Wound Repair Regen"},{"key":"ref27","unstructured":"WHO (2015) WHO Drug Information. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/appswhoint\/medicinedocs\/documents\/s22000en\/s22000enpdf\" xlink:type=\"simple\">http:\/\/appswhoint\/medicinedocs\/documents\/s22000en\/s22000enpdf<\/ext-link> 29: 242."},{"key":"ref28","first-page":"23","article-title":"Vaccination with messenger RNA","volume":"127","author":"S Pascolo","year":"2006","journal-title":"Methods Mol Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-540-72167-3_11","article-title":"Vaccination with messenger RNA (mRNA)","author":"S Pascolo","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"F Cliquet","year":"1998","journal-title":"Journal of Immunological Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/312548a0","article-title":"Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo","volume":"312","author":"SP Cobbold","year":"1984","journal-title":"Nature"},{"key":"ref32","first-page":"493","article-title":"A simple method of estimation of fifty percent end points","volume":"27","author":"LJMH Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/JCM.00612-10","article-title":"Improved safety for molecular diagnosis of classical rabies viruses by use of a TaqMan real-time reverse transcription-PCR &quot;double check&quot; strategy","volume":"48","author":"B Hoffmann","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"B Petsch","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"H Watanabe","year":"2004","journal-title":"Shock"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-1157(84)80019-0","article-title":"A new inactivated tissue culture rabies vaccine for use in man. Evaluation of PCEC-vaccine by laboratory tests","volume":"12","author":"R Barth","year":"1984","journal-title":"Journal of Biological Standardization"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1016\/j.vaccine.2008.09.055","article-title":"A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge","volume":"26","author":"S Saxena","year":"2008","journal-title":"Vaccine"},{"key":"ref38","first-page":"255","article-title":"Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin","volume":"40","author":"TJ Wiktor","year":"1978","journal-title":"Developments in Biological Standardization"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.141.8.2721","article-title":"Genetic restriction and fine specificity of human T cell clones reactive with rabies virus","volume":"141","author":"E Celis","year":"1988","journal-title":"Journal of Immunology (Baltimore, Md: 1950)"},{"key":"ref40","author":"F.-X. KMM Meslin","year":"1996"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01320-6","article-title":"The blood-brain barrier in neuroinflammatory diseases","volume":"49","author":"HE de Vries","year":"1997","journal-title":"Pharmacological Reviews"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.4049\/jimmunol.176.12.7666","article-title":"Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system","volume":"176","author":"TW Phares","year":"2006","journal-title":"Journal of Immunology (Baltimore, Md: 1950)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2009.09.019","article-title":"Correlation of cytokine expression with rabies virus distribution in rabies encephalitis","volume":"217","author":"A Solanki","year":"2009","journal-title":"Journal of Neuroimmunology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tim.2011.11.002","article-title":"The pig: a model for human infectious diseases","volume":"20","author":"F Meurens","year":"2012","journal-title":"Trends Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.dci.2014.03.022","article-title":"The porcine innate immune system: an update","volume":"45","author":"KH Mair","year":"2014","journal-title":"Dev Comp Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2013.01.003","article-title":"Current and future approaches to the therapy of human rabies","volume":"99","author":"AC Jackson","year":"2013","journal-title":"Antiviral Research"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1473-3099(12)70096-8","article-title":"Global rabies elimination: are we stepping up to the challenge?","volume":"12","author":"K Senior","year":"2012","journal-title":"The Lancet Infectious Diseases"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e0004433","DOI":"10.1371\/journal.pntd.0004433","article-title":"Surveillance of Canine Rabies in the Central African Republic: Impact on Human Health and Molecular Epidemiology","volume":"10","author":"V Tricou","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0264-410X(91)90188-C","article-title":"The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines","volume":"9","author":"PS Wunderli","year":"1991","journal-title":"Vaccine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2460\/ajvr.2003.64.491","article-title":"Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice","volume":"64","author":"PS Wunderli","year":"2003","journal-title":"American Journal of Veterinary Research"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000535","article-title":"The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system","volume":"3","author":"DC Hooper","year":"2009","journal-title":"PLoS neglected tropical diseases"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.vaccine.2009.01.128","article-title":"Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challenge","volume":"27","author":"M Kaur","year":"2009","journal-title":"Vaccine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1096\/fj.09-138644","article-title":"Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB\/c mice","volume":"24","author":"M Kaur","year":"2010","journal-title":"FASEB J"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.4049\/jimmunol.178.11.7334","article-title":"A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient","volume":"178","author":"TW Phares","year":"2007","journal-title":"Journal of Immunology (Baltimore, Md: 1950)"},{"key":"ref55","unstructured":"Stitz L, Vogel A, Schnee M, Voss D, Rauch S, et al. A thermostable messenger RNA based vaccine (manuscript in preparation)."}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T18:34:36Z","timestamp":1748975676000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004746"}},"subtitle":[],"editor":[{"given":"Charles E","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.g003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.g004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.g005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.g006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0004746.s004","asserted-by":"subject"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,23]]}}}